The regulatory landscape is evolving: in February 2026, HHS announced that approximately 14 previously restricted peptides including BPC-157, TB-500, CJC-1295, Ipamorelin, and Sermorelin are expected to return to Category 1 compounding status
Theres currently no statutory requirement restricting who can administer it, which is a gap the JCCP has been campaigning to close
Structure and function of the bloodbrain barrier
From brighter skin to better liver support, these promises catch peoples attention and spark hope that glutathione injections might be the quick answer to feeling and looking better
You may also have temporary mild itchiness and/or redness on your skin at the site of the injections
However, excessive usage may lead to different side effects on the skin and body